The rare inflammatory diseases treatment industry was valued at US$12,664 million in 2021; analysts predict it will grow at a rate of 4.6% between 2022 and 2028 to reach US$17,335.8 million. The rare inflammatory disease treatment market has witnessed remarkable growth and innovation in recent years, owing to increasing awareness and advancements in medical research. Rare …